KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Resmed (RMD) Shares Repurchased (2018 - 2025)

Historic Shares Repurchased for Resmed (RMD) over the last 11 years, with Q4 2025 value amounting to $175.0 million.

  • Resmed's Shares Repurchased rose 13339.56% to $175.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $500.1 million, marking a year-over-year increase of 12225.29%. This contributed to the annual value of $300.0 million for FY2025, which is 10000.2% up from last year.
  • Resmed's Shares Repurchased amounted to $175.0 million in Q4 2025, which was up 13339.56% from $150.0 million recorded in Q3 2025.
  • Resmed's 5-year Shares Repurchased high stood at $175.0 million for Q4 2025, and its period low was $50.0 million during Q1 2024.
  • Its 3-year average for Shares Repurchased is $86.1 million, with a median of $75.0 million in 2024.
  • Its Shares Repurchased has fluctuated over the past 5 years, first skyrocketed by 4995.1% in 2024, then soared by 19999.0% in 2025.
  • Resmed's Shares Repurchased (Quarter) stood at $50.0 million in 2023, then surged by 49.95% to $75.0 million in 2024, then surged by 133.4% to $175.0 million in 2025.
  • Its Shares Repurchased was $175.0 million in Q4 2025, compared to $150.0 million in Q3 2025 and $100.0 million in Q2 2025.